At AVIGI Therapeutics, we don’t just think outside the box—we dissolve it, analyze it, and reassemble it into something extraordinary. Our journey began with an unlikely hero: the disaccharide. These small sugar molecules may seem unassuming, but within their structure lies the blueprint for a groundbreaking heparanase inhibitor.

Why heparanase? This enzyme plays a key role in tissue remodeling, cancer metastasis, and inflammatory diseases, making it a prime target for therapeutic intervention. Inspired by nature’s own molecules, our team engineered a disaccharide-inspired inhibitor capable of selectively halting heparanase activity without disrupting healthy cellular processes.

This was innovation + biomimicry at its finest, with added scientific flair for problem-solving. By applying design principles to our understanding of molecular interactions and biology, we’ve turned a humble sugar into a precision therapeutic tool against some of the toughest diseases.

Follow our advancement by subscribing